ABSTRACT
People are focusing their attention on personal health in the current situation. Medicine has an important function to play in maintaining our health. Researchers developed various compounds to cure important health issues such as cancer, diabetes, and tuberculosis, among others. We are focusing on Carfilzomib, an anti-cancer drug supplement. The present work discusses the development and validation of the UV Spectrophotometric method for carfilzomib. Simple, specific, and economic purposes UV spectrophotometric method has been developed using the methanol as a diluent to the estimation of carfilzomib in vial formulation. The lmax of carfilzomib was found to be 203 nm. The linearity in the concentration range 4-16 mg/ml was founded to have a good correlation coefficient (R2 = 0.9952). The accuracy was between (99.4-101.2%), The LOD and LOQ are 0.00156 mg/ml and 0.00472 mg/ml respectively.
Support the magazine and subscribe to the content
This is premium stuff. Subscribe to read the entire article.
